跳至主要内容
临床试验/CTRI/2023/09/057289
CTRI/2023/09/057289招募中Unknown

Investigating the pathomechanisms underlying the RNA exosome component EXOSC1 associated neurodegenerative disorder - EXOSC1

Science and Engineering Research Board (SERB)0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Inclusion criteria (primary fibroblast to iPSC generation): subject with neurodegenerative pontocerebellar hypoplasia type 1F and pathogenic variant in EXOSC1 will be recruited into the study.
  • – Inclusion criteria (primary fibroblast studies): subjects with pathogenic variants in RNA exosome component genes, eg. EXOSC5, EXOSC6, EXOSC7, EXOSC8 etc will be included in the study

排除标准

  • – Exclusion criteria (primary fibroblast to iPSC generation): subjects without pathogenic variants in EXOSC1 will be excluded.
  • – Exclusion criteria (primary fibroblast studies): subjects with no pathogenic variants in RNA exosome genes will be excluded

研究者

发起方
Science and Engineering Research Board (SERB)

相似试验